Evrofarma SA (EVROF) — Strategic Asset Allocation Index

Evrofarma SA (EVROF) has a Strategic Asset Allocation Index of 172.2% as of December 2022. Strategic assets (PP&E of €24.15 Million plus long-term investments of €-) total €24.15 Million, measured against net assets of €14.03 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See EVROF equity financing ratio to measure how much of total assets are equity-financed.